Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:2821257rdf:typepubmed:Citationlld:pubmed
pubmed-article:2821257lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:2821257lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:2821257lifeskim:mentionsumls-concept:C0205369lld:lifeskim
pubmed-article:2821257lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:2821257lifeskim:mentionsumls-concept:C1149380lld:lifeskim
pubmed-article:2821257lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:2821257pubmed:issue10lld:pubmed
pubmed-article:2821257pubmed:dateCreated1987-11-6lld:pubmed
pubmed-article:2821257pubmed:abstractTextA series of 1,3-diarylpyrazolo[4,5-c]- and -[5,4-c]quinolin-4-ones were prepared and tested for their ability to displace [3H]flunitrazepam from bovine brain membranes. While the 1,3-diarylpyrazolo[4,5-c]quinoline derivatives showed affinity for the receptor site, their [5,4-c] isomers were devoid of binding activity.lld:pubmed
pubmed-article:2821257pubmed:languageenglld:pubmed
pubmed-article:2821257pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2821257pubmed:citationSubsetIMlld:pubmed
pubmed-article:2821257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2821257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2821257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2821257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:2821257pubmed:statusMEDLINElld:pubmed
pubmed-article:2821257pubmed:monthOctlld:pubmed
pubmed-article:2821257pubmed:issn0022-2623lld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:LucacchiniAAlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:MelaniFFlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:CecchiLLlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:MartinsUUlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:FilacchioniGGlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:ColottaVVlld:pubmed
pubmed-article:2821257pubmed:authorpubmed-author:PalazzinoGGlld:pubmed
pubmed-article:2821257pubmed:issnTypePrintlld:pubmed
pubmed-article:2821257pubmed:volume30lld:pubmed
pubmed-article:2821257pubmed:ownerNLMlld:pubmed
pubmed-article:2821257pubmed:authorsCompleteYlld:pubmed
pubmed-article:2821257pubmed:pagination1737-42lld:pubmed
pubmed-article:2821257pubmed:dateRevised2003-11-14lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:meshHeadingpubmed-meshheading:2821257-...lld:pubmed
pubmed-article:2821257pubmed:year1987lld:pubmed
pubmed-article:2821257pubmed:articleTitle1,3-Diarylpyrazolo[4,5-c]- and -[5,4-c]quinolin-4-ones. 4. Synthesis and specific inhibition of benzodiazepine receptor binding.lld:pubmed
pubmed-article:2821257pubmed:affiliationDipartimento di Scienze Farmaceutiche, Università di Firenze, Italy.lld:pubmed
pubmed-article:2821257pubmed:publicationTypeJournal Articlelld:pubmed
http://linkedlifedata.com/r...http://linkedlifedata.com/r...pubmed-article:2821257lld:chembl